|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effects of denosumab on bonemineral density and bone turnover in patients with rheumatoidarthritis receiving concurrent glucocorticoids or bisphosphonates显示文摘 | Dore RK Cohen SB Lane NE | 2010 | Ann Rheum Dis2010，69，5： | 1 |
| 2 | Denosumab treatment effects on structural damage,bone mineral density,and hone turnover in theumatoid arthritis:twelve-month,multicenter,randomized,double-blind,placebo-controlled,phase II clinical trial显示文摘 | Cohen SB Dore RK Lane NE | 2008 | Arthritis Rheum2008，58，： | 1 |
| 3 | Long-term safety, efficacy, and patient acceptability of teriparatide in the management of glucocorticoid-induced osteopo- rosis显示文摘 | Dore RK | 2013 | Patient Prefer Adher2013，7，： | 1 |
| 4 | How to prevent glucocorticoid-induced osteoporosis 显示文摘 | Dore RK | 2010 | Cleve Clin J Med2010，77，8： | 1 |
| 5 | Denosumab treatmenteffects on structural damage,bone mineral density,and boneturnover in rheumatoid arthritis:a twelve-month,multicenter,randomized,double-blind,placebo-controlled,phase II clinicaltrial显示文摘 | Cohen SB Dore RK Lane NE | 2008 | Arthritis Rheum2008，58，5： | 1 |
| 6 | Reduced risk of back pain fol-lowing teriparatide treatment:a meta-analysis显示文摘 | Nevitt MC Chen P Dore RK | 2006 | Osteoporos Int-2006，17，2： | 1 |
| 7 | Denosumab treatment ef- fects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multieenter, randomized, double-blind, placebo-controlled, phase ]I clinical trial显示文摘 | Cohen SB Dore RK Lane NE | 2008 | Arthritis Rheum2008，58，5： | 1 |
| 8 | How to prevent glucocorticoid-induced osteoporosis显示文摘 | Dore RK | 2010 | Cleve Clin J Med2010，77，8： | 1 |
| 9 | Denosumab treatment effects on structural damadge,bone mineral density,and bone turnover in rheumatoid arthritis:a twelve-month,multicenter,randomized,double-blind,placebo-controlled,phase H clinical trial显示文摘 | Cohen SB Dore RK Lane NE | 2008 | Arthritis Rheum2008，58，5： | 1 |
| 10 | Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, p|acebo-controlled, phase II clinical trial显示文摘 | Cohen SB Dore RK Lane NE | 2008 | Arthritis Rheum2008，58，5： | 1 |
| 11 | Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates 显示文摘 | Dore RK Cohen SB Lane NE | 2010 | Ann Rheum Dis2010，69，5： | 1 |
| 12 | Denosumab treat-ment effects on structural damage,bone mineral density,and bone turnover in rheumatoid arthritis : a twelve-month ,multicenter,randomized,double-blind,placebo-controlled ,phase II clinical trial 显示文摘 | Cohen SB Dore RK Lane NE | 2008 | J Arthritis Rheum2008，58，5： | 1 |
| 13 | Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid ar- thritis receiving concurrent glucocorticoids or bisphosphonates 显示文摘 | Dore RK Cohen SB Lane NE | 2010 | Ann Rheum Dis2010，69，5： | 1 |
| 14 | Cevimeline for the treatment of xerostomia in patients with Sjogren syndrome: a randomized trial 显示文摘 | Fife RS Chase WF Dore RK | 2002 | Arch Intern Med2002，162，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员